First Round of Late-Breaking Clinical Trial Results Announced at VIVA21
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...
United States Wynn Las Vegas Howardm Julien Erica Secemsky Gunnar Tepe Boston Scientific Corporation
Source: prnewswire.com